Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025
Compare Balance Sheet Results of Link Pharma Chem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.44
0.90
3.54
393.33%
Share Warrants & Outstandings
Total Reserve
8.35
3.14
5.21
165.92%
Shareholder's Funds
12.79
4.04
8.75
216.58%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.70
4.32
-3.62
-83.80%
Secured Loans
0.70
2.11
-1.41
-66.82%
Unsecured Loans
0.00
2.21
-2.21
-100.00%
Deferred Tax Assets / Liabilities
-0.16
0.38
-0.54
-142.11%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.24
0.00
0.24
0.00%
Total Non-Current Liabilities
0.77
4.69
-3.92
-83.58%
Current Liabilities
Trade Payables
3.25
9.52
-6.27
-65.86%
Other Current Liabilities
0.88
0.30
0.58
193.33%
Short Term Borrowings
6.61
6.53
0.08
1.23%
Short Term Provisions
0.50
0.27
0.23
85.19%
Total Current Liabilities
11.24
16.62
-5.38
-32.37%
Total Liabilities
24.81
25.35
-0.54
-2.13%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.01
10.67
7.34
68.79%
Less: Accumulated Depreciation
7.63
5.50
2.13
38.73%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.38
5.17
5.21
100.77%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
2.49
-2.49
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
2.47
0.36
2.11
586.11%
Long Term Loans & Advances
0.58
0.00
0.58
0.00%
Other Non Current Assets
0.04
0.31
-0.27
-87.10%
Total Non-Current Assets
13.46
8.33
5.13
61.58%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.02
5.86
-0.84
-14.33%
Sundry Debtors
5.28
9.71
-4.43
-45.62%
Cash and Bank
0.63
0.69
-0.06
-8.70%
Other Current Assets
0.07
0.74
-0.67
-90.54%
Short Term Loans and Advances
0.34
0.00
0.34
0.00%
Total Current Assets
11.34
17.02
-5.68
-33.37%
Net Current Assets (Including Current Investments)
0.10
0.40
-0.30
-75.00%
Total Current Assets Excluding Current Investments
11.34
17.02
-5.68
-33.37%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
24.81
25.35
-0.54
-2.13%
Contingent Liabilities
1.61
0.00
1.61
0.00%
Total Debt
7.30
10.85
-3.55
-32.72%
Book Value per share (adjusted)
28.80
43.79
-14.99
-34.23%
Annual - Borrowings
Borrowings 7.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 26.30% vs -37.31% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 11.85% vs -6.64% in Mar 2025
Annual - Investments
Investments 2.47 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.90% vs -29.69% in Mar 2025
Annual - Current Assets
Current Assets 11.34 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.61% vs -3.21% in Mar 2025
